Hepatic Mass ICD-10-CM Codes
Learn about Hepatic Mass ICD-10-CM codes in 2023. This thorough manual contains billable codes, clinical descriptions, synonyms, and more information.
Fact Checked by Ericka Pingol.
What ICD-10 Codes are Used for Hepatic Mass?
Hepatic Mass refers to abnormal growths or tumors in the liver. Accurate ICD-10-CM codes are essential for medical billing and documentation. Below are the commonly used codes for Hepatic Mass:
C22.0 - Liver cell carcinoma: This code is used when the hepatic mass is identified as hepatocellular carcinoma. This indicates that your liver's cells have multiplied out of control.
C22.2 - Hepatoblastoma: This code is used for hepatoblastoma. Hepatoblastoma is a malignant liver tumor primarily found in infants and children, primarily in the liver. It comprises immature hepatocytic elements and is treated with surgical excision and adjuvant therapy.
D13.5 Benign neoplasm: Extrahepatic bile ducts and gall bladder: This code is used for benign neoplasms or tumors of the liver. Abnormal tissue growth in the gallbladder or bile ducts is benign, not a tumor, as it occurs in the liver and is not harmful to healthy tissue.
D13.6: Benign neoplasm: Pancreas: This code covers benign liver neoplasms not classified elsewhere. Abnormal pancreatic tissue growth, also known as a tumor, affects the pancreas, which produces messenger substances and fluids for digestion. This benign growth affects the pancreas' ability to control blood sugar levels and digest fats, proteins, and sugars.
Which Hepatic Mass ICD codes are Billable?
The following ICD-10-CM codes for Hepatic Mass are billable:
C22.0 - Yes, billable: Liver cell carcinoma (Hepatocellular Carcinoma) is eligible for reimbursement when accurately coded.
C22.2 - Yes, billable: Hepatoblastoma is eligible for reimbursement when accurately coded.
D13.5 - Yes, billable: Benign neoplasm: Extrahepatic bile ducts and gall bladder can be billed when documented accurately.
D13.6 - Yes, billable: Benign neoplasm: Pancreas are eligible for reimbursement.
Clinical Information
- A hepatic mass refers to an abnormal growth or lump in the liver.
- It can be benign (non-cancerous) or malignant (cancerous).
- Common benign hepatic masses include hepatic hemangiomas and focal nodular hyperplasia.
- Malignant hepatic masses can be primary liver cancers (hepatocellular carcinoma) or metastatic tumors from other sites.
- Symptoms, including abdominal pain, jaundice, weight loss, and fatigue, may not be present early.
- Diagnosis involves imaging tests like ultrasound, CT scans, and MRIs to assess the mass's characteristics.
- A biopsy may be necessary to determine if the mass is cancerous and its specific type.
- Treatment depends on the mass's type, size, and location, from observation to surgery, chemotherapy, or targeted therapies.
- Management aims to address the underlying cause and improve prognosis and quality of life.
- Regular medical follow-up and monitoring are essential, especially for malignant hepatic masses.
Synonyms Include
- Liver Tumor
- Liver Growth
- Hepatic Neoplasm
- Liver Mass
.png)
Commonly asked questions
No, hepatic masses can be benign (non-cancerous) or malignant (cancerous). Accurate diagnosis and appropriate testing are essential to determine the nature of the mass.
Common symptoms may include abdominal pain, unexplained weight loss, jaundice (yellowing of the skin and eyes), and changes in appetite.
Diagnosis typically involves imaging tests such as ultrasound, CT scans, and MRI, along with further evaluation through biopsy to determine the nature of the mass.
